
Regulatory Hurdles in India’s Clinical Research Landscape: Where Innovation Slows Down
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its
We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science

At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.

India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its

The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant

Need of Good Clinical Practice (GCP) Compliance for Clinical Trial Success In clinical research, the success of drug approval versus

Pharma Lifecycle Management is essential in the highly regulated pharmaceutical industry, where the product lifecycle extends beyond market

Clinical trials have evolved from isolated studies to ones that leverage decades of accumulated evidence and prior research, yet traditional

For export-oriented pharmaceutical companies, a PIC/S GMP certificate serves as a strategic passport to global markets and is crucial for
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.